Search clinical trials for: DLQI

Total 26 results

Buddhist Tzu Chi General Hospital

Recruiting

To Evaluate the Mechanism of Jing Si Herbal Tea Liquid Packets and Traditional Western Medicine for Psoriasis

DLQI | PHQ-9 | PSAI | Serum Cytokine Survey

Taiwan
Clinact
LEO Pharma

Completed

Evaluation of the Sensitivity and Specificity of a Novel Quality of Life Tool to Assess the Treatment Satisfaction in Psoriasis Patients (PSO-TARGET)

Psoriasis

France, Belgium
Region Östergötland

Completed

Patient Satisfaction and Safety of Miradry Treatment for Axillary Hyperhidrosis

Axillary Hyperhidrosis

Sweden
University Hospital, Ghent
KU Leuven

Completed

A Non-inferiority Study on Dose Reduction of Adalimumab in Psoriasis Patients Who Are Overtreated

Psoriasis

Belgium
Pierre Fabre Dermo Cosmetique

Completed

Efficacy Study of Cosmetic Product on Xerosis Induced by Systemic Anticancer Treatments

Xerosis

France
Centre Leon Berard

Completed

Satisfaction and Quality of Life Comparison Between Patients Using Cicaplast Baume B5 Versus Dexeryl for the Management of Cutaneous Toxicities Induced by Epidermal Growth Factor Receptor Inhibitors (iEGFR) (CICAFIX)

Colorectal Cancer | Non Small Cell Lung Cancer | Head and Neck Squamous Cell Carcinoma | Epidermal Growth Factor Receptor Inhibitor

France
Washington University School of Medicine
Merck Sharp & Dohme LLC

Terminated

Epicutaneous Cryoimmunotherapy Combined With Pembrolizumab for Cutaneous Metastatic Breast Cancer

Metastatic Breast Cancer

United States
Cairo University

Completed

Paraffin Bath Therapy for Chronic Hand Eczema

Eczema

Saudi Arabia
Pfizer

Completed

Open-Label Extension Study Of Tofacitinib In Psoriatic Arthritis (OPAL BALANCE)

Arthritis, Psoriatic

Belgium, United States, Canada, Spain, Australia, Taiwan, Czechia, Hungary, Germany, Mexico, Poland, Russian Federation, Slovakia, United Kingdom, Brazil, Bulgaria
Jinnah Postgraduate Medical Centre

Completed

Efficacy of Saline Injection Therapy in Atrophic Acne Scars

Scars | Atrophic

Pakistan
Association Francaise pour la Recherche Thermale
University Hospital, Grenoble; Floralis

Completed

Evaluation of Spa Therapy in the Treatment of Plaque Psoriasis

Plaque Psoriasis

France
Pfizer

Completed

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Asian Subjects With Moderate To Severe Plaque Psoriasis

Psoriasis

Korea, Republic of, Taiwan, China
Pfizer

Completed

A Phase 3, Multi Site, Randomized, Double Blind, Placebo Controlled Study Of The Efficacy And Safety Comparing CP- 690,550 And Etanercept In Subjects With Moderate To Severe Chronic Plaque Psoriasis

Psoriasis

Belgium, Spain, Germany, France, Hungary, Russian Federation, Singapore, Argentina, Austria, Bosnia and Herzegovina, Bulgaria, Chile, Colombia, Croatia, Czechia, Denmark, Hong Kong, Israel, Korea, Republic of, Netherlands, Poland, Slovaki... and more
Pfizer

Completed

A Study To Evaluate The Effects And Safety Of Treatment, Treatment Withdrawal, Followed By Re-Treatment With CP-690,550 In Subjects With Moderate To Severe Chronic Plaque Psoriasis

Psoriasis

United States, Denmark, Slovakia, Canada, Australia, Argentina, Bulgaria, Netherlands, United Kingdom, Brazil, Finland, Greece
Wake Forest University

Completed

Development and Validation of a Quality of Life Instrument for Actinic Keratosis (AKRQ)

Actinic Keratosis

United States
AbbVie (prior sponsor, Abbott)
Raffeiner GmbH

Completed

Effectiveness of Adalimumab in Moderate to Severe Plaque Psoriasis Patients With Distinct Co-morbidities (EPIC)

Moderate to Severe Plaque Psoriasis
GlaxoSmithKline

Completed

A Dose Ranging Study to Evaluate the Safety and Efficacy of GSK2586184 in Patients With Chronic Plaque Psoriasis

Psoriasis

Germany, United Kingdom
Novartis Pharmaceuticals

Completed

Multiple-dose Regimen Study to Assess Effect of 12 Months of Secukinumab Treatment on Skin Response and Biomarkers in Psoriasis Patients

Psoriasis, Plaque-type Psoriasis

United States
Pfizer

Completed

A One-Year Study To Evaluate The Efficacy And Safety Of CP-690,550 For Patients With Moderate To Severe Chronic Plaque Psoriasis

Psoriasis

United States, Canada, Poland, Serbia, Germany, Ukraine, Taiwan, Mexico, Colombia, Hungary, Puerto Rico
Pfizer

Completed

A One-Year Study To Evaluate The Effects And Safety Of CP-690,550 In Patients With Moderate To Severe Chronic Plaque Psoriasis

Psoriasis

United States, Canada, Germany, Colombia, Hungary, Japan, Mexico, Poland, Serbia, Taiwan, Ukraine
Annesofie Faurschou
University of Copenhagen

Completed

The Effect of Glucagon Like Peptide (GLP)-1 in Psoriasis

Psoriasis

Denmark
Abbott
Assign Data Management and Biostatistics GmbH

Completed

Quality of Life in Adalimumab Treated Psoriasis Patients Failing Other Biologic Disease Modifying Anti-rheumatic Drugs (QUALITY)

Psoriasis Chronic

Austria
University Hospital, Gentofte, Copenhagen

Unknown

GLP-1 Receptors in Normal Skin and Skin From Patients With Psoriasis

Reduction of Psoriasis Following Liraglutide Therapy in Terms of PASI and DLQI

Denmark
Chulalongkorn University

Unknown

Efficacy of Vitamin D3 for the Treatment of Psoriatic Patients With Vitamin D Deficiency and Insufficiency

Vitamin D Deficiency | Psoriasis Vulgaris

Thailand
Technische Universität Dresden

Completed

Prednisolone vs. Ciclosporine in Severe Atopic Eczema (PROVE)

Atopic Dermatitis

Germany, Austria
Henry Ford Health System

Unknown

Xeroderma Pigmentosum Patient Experiences

Xeroderma Pigmentosum

United States

Search clinical trials for: DLQI

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Rwanda

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations